Immunotherapy for prostate cancer using prostatic acid phosphatase loaded antigen presenting cells
/in International Publications, Prostate Cancer /von 2006-09-01 / Urol. Oncol. 2006 Sep-Oct;24(5):434-41Basic overview of current immunotherapy approaches in urologic malignancy
/in International Publications, Prostate Cancer /von 2006-09-01 / Urol. Oncol. 2006 Sep-Oct;24(5):413-8[Immunotherapeutic effects of beta-elemene combined with interleukin-23 gene-modified dendritic cells on murine pancreatic carcinoma]
/in International Publications, Pancreatic Cancer /von 2006-09-01 / Ai Zheng 2006 Sep;25(9):1082-6Immunesurveillance by dendritic cells: potential implication for immunotherapy of endocrine cancers
/in Dendritic Cells, International Publications, Thyroid Cancer /von 2006-09-01 / Endocr. Relat. Cancer 2006 Sep;13(3):779-95Improved overall survival in dendritic cell vaccination-induced immunoreactive subgroup of advanced melanoma patients
/in Dendritic Cells, International Publications, Malignant Melanoma /von 2006-08-16 / J Transl Med 2006 Aug;4:36Immunotherapy for prostate cancer: what’s the future?
/in International Publications, Prostate Cancer /von 2006-08-01 / Hematol. Oncol. Clin. North Am. 2006 Aug;20(4):965-83, xiNewcastle disease virus exerts oncolysis by both intrinsic and extrinsic caspase-dependent pathways of cell death
/in International Publications, Newcastle Disease Virus /von 2006-08-01 / J. Virol. 2006 Aug;80(15):7522-34Antitumor immune response induced by i.t. injection of vector-activated dendritic cells and chemotherapy suppresses metastatic breast cancer
/in Breast Cancer, International Publications /von 2006-08-01 / Mol. Cancer Ther. 2006 Aug;5(8):1975-85Targeting the heat shock factor 1 by RNA interference: a potent tool to enhance hyperthermochemotherapy efficacy in cervical cancer
/in Cervical Cancer, International Publications /von 2006-08-01 / Cancer Res. 2006 Aug;66(15):7678-85
IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de